Cargando…
Tapentadol extended release in the management of peripheral diabetic neuropathic pain
Tapentadol, a μ-opioid agonist and norepinephrine reuptake inhibitor, has been found to be an effective medication for a wide variety of chronic pain conditions, including back pain, cancer-related pain, and arthritic pain. It has also been found to have fewer gastrointestinal side effects than more...
Autores principales: | Vadivelu, Nalini, Kai, Alice, Maslin, Benjamin, Kodumudi, Gopal, Legler, Aron, Berger, Jack M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298300/ https://www.ncbi.nlm.nih.gov/pubmed/25609974 http://dx.doi.org/10.2147/TCRM.S32193 |
Ejemplares similares
-
Tapentadol extended-release for treatment of chronic pain: a review
por: Vadivelu, Nalini, et al.
Publicado: (2011) -
Options for perioperative pain management in neurosurgery
por: Vadivelu, Nalini, et al.
Publicado: (2016) -
Challenges of pain control and the role of the ambulatory pain specialist in the outpatient surgery setting
por: Vadivelu, Nalini, et al.
Publicado: (2016) -
Tapentadol extended release for the management of chronic neck pain
por: Billeci, Domenico, et al.
Publicado: (2017) -
Patient considerations in the use of tapentadol for moderate to severe pain
por: Vadivelu, Nalini, et al.
Publicado: (2013)